查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年各服務（個人、非個人促銷）、最終用途（製藥公司、生物製藥公司）、地區、細分趨勢的合同銷售代理市場規模、份額、趨勢分析報告
市場調查報告書
商品編碼
1233195

2023-2030 年各服務（個人、非個人促銷）、最終用途（製藥公司、生物製藥公司）、地區、細分趨勢的合同銷售代理市場規模、份額、趨勢分析報告

Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Services (Personal, Non-personal Promotion), By End-use (Pharma, Biopharma Companies), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

合同營銷代理市場的增長和趨勢

Grand View Research, Inc. 的一份新報告顯示，全球合同銷售代理市場規模從 2023 年到 2030 年將以 8.4% 的複合年增長率增長，到 2030 年將達到 163%。預計將達到美國10億美元。

合同銷售組織 (CSO) 對寄售新技術的採用率很高，最終用戶對擴大生物製藥和小分子藥物的銷售越來越感興趣，並且對與內部相關的成本削減需求迅速增加銷售是支持該行業增長的一些關鍵因素。 近年來，新藥上市數量不斷增加。

例如，根據 IQVIA 研發趨勢報告，2021 年全球將推出 84 種新的活性物質，比過去五年翻了一番。 預計全球藥物上市的增加將提振對合同銷售服務的需求，這可能會支持該行業的增長。 處方藥的銷售額正在穩步增長。 例如，根據 Evaluate Pharma 的數據，2021 年全球處方藥總銷售額將達到 1.66 萬億美元，到 2028 年將達到 1.612 萬億美元。 預計製藥公司不斷增長的銷售需求將推動大流行後對製藥業 CSO 服務的需求。

醫藥合同營銷代理市場報告亮點

  • 在服務方面，個人促銷部門在 2022 年主導了該行業。 由於製藥公司研發活動的增加，預計新藥上市數量將增加，預計批准將支持該領域的增長。
  • 由於製藥公司在產品銷售方面的激烈競爭推動了對支持銷售業務的高效團隊的需求，因此製藥最終用途部門在 2022 年的收入份額最大。
  • 北美在 2022 年的收入份額最大。 該地區在過去幾年中推出了大量藥物，主要是在美國，這是支持該地區增長的關鍵因素之一。
  • 此外，該地區的公共機構正在穩步加大資金支持研發活動的力度。 這進一步推動了該地區的增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 服務
    • 最終用途
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析（模型 1）
    • 批量價格分析（模型 2）
  • 二級信息列表
  • 主要信息列表
  • 目的

第 2 章執行摘要

  • 市場展望

第 3 章合同銷售組織 (CSO) 市場的變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場前景
  • 市場動態
    • 市場驅動因素分析
      • 增加了藥物研發活動並增加了藥物管線
      • 製藥公司對促進產品銷售的興趣增加
      • 數字技術在醫藥合同銷售組織中的應用
    • 市場製約因素分析
      • 與外包相關的質量問題
    • COVID-19 的影響和恢復分析
    • 行業分析 - 波特五力模型
    • PESTLE 分析

第 4 章合同銷售組織 (CSO) 市場：服務細分分析

  • 合同銷售組織 (CSO) 市場：定義和範圍
  • CSA 市場 (CSO) 市場：服務市場份額分析，2022 年和 2030 年
    • 個人宣傳
      • 促銷銷售團隊
      • 大客戶管理
      • 職位空缺管理
    • 非個人促銷
      • 醫療解決方案
      • 遠程醫療科學聯絡員
      • 護士（臨床）教育家
      • 其他

第 5 章合同銷售組織 (CSO) 市場：最終用途細分分析

  • 合同銷售組織 (CSO) 市場：定義和範圍
  • 合同銷售組織 (CSO) 市場：最終用途市場份額分析，2022 年和 2030 年
    • 製藥公司
    • 生物製藥公司

第 6 章合同銷售組織 (CSO) 市場：區域分析

  • 合同銷售組織 (CSO) 市場：區域市場份額分析，2022 年和 2030 年
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
      • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第七章競爭格局

  • 中美國際控股有限公司
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • 阿克塞勒斯
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • EPS 公司。
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • QFR 解決方案
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • 馬比科
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Mednext Pharma 私人有限公司
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Peak Pharma Solutions Inc.
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • 艾昆緯公司
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Promoveo 健康
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Syneous 健康
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
Product Code: GVR-4-68040-034-7

Pharmaceutical Contract Sales Organizations Market Growth & Trends:

The global pharmaceutical contract sales organizations market size is expected to reach USD 16.3 billion by 2030, registering a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. High adoption of new technologies for contract sales by pharmaceutical contract sales organizations (CSO), an increase in the interest among end-users to increase the sales of biopharmaceutical and small molecule drugs, and the surge in demand for reducing the cost associated with in-house sales are some of the key factors supporting the growth of the industry. Over the years, the number of new drug launches has increased.

For instance, according to the IQVIA report on R&D trends, 84 new active substances were launched globally in 2021, which was double as compared to the last five years. The increase in drug launches globally is expected to improve the demand for contract sales services, which is likely to support industry growth. Prescription drug sales are witnessing a steady rise. For instance, according to Evaluate Pharma, worldwide total prescription drug sales accounted for USD 1,066 billion in 2021 and will reach USD 1,612 billion by 2028. The growing demand for sales among pharmaceutical companies is expected to improve the demand for CSO services for pharmaceuticals in the post-pandemic period.

Pharmaceutical Contract Sales Organizations Market Report Highlights:

  • Based on service, the personal promotion segment dominated the industry in 2022. A rise in the R&D activities of pharmaceutical companies is expected to increase the number of new drug launches, and approvals are expected to support the segment growth
  • The pharmaceutical companies end-use segment held the largest revenue share in 2022 due to the high competition among pharmaceutical companies in product sales, promoting the demand for an efficient team to support their sales activities
  • North America held the largest revenue share in 2022. A significant number of drugs were launched in the region in the previous years, especially in the U.S., which is one of the key factors supporting the region's growth
  • Moreover, the region's public organization is steadily focused on supporting R&D activities by providing funding. This has further supported the region's growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Service
    • 1.1.2. End-use
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Pharmaceutical Contract Sales Organization Market (CSO) Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increase the R&D activities on drugs and increase in the drug pipeline
      • 3.2.1.2. Growing interest of pharmaceutical companies to increase the sales of the products
      • 3.2.1.3. Adoption of digital technologies by Pharmaceutical Contract Sales Organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Quality issues associated with outsourcing
    • 3.2.3. Covid-19 Impact & Recovery Analysis
    • 3.2.4. Industry Analysis - Porter's Five Forces
    • 3.2.5. PESTLE Analysis

Chapter 4. Pharmaceutical Contract Sales Organization Market (CSO): Service Segment Analysis

  • 4.1. Pharmaceutical Contract Sales Organization Market (CSO) Market: Definition & Scope
  • 4.2. Pharmaceutical Contract Sales Organization Market (CSO) Market: Service Market Share Analysis, 2022 & 2030
    • 4.2.1. Personal Promotion
      • 4.2.1.1. Personal promotion market, 2018 - 2030 (USD Million)
      • 4.2.1.2. Promotional sales team
      • 4.2.1.2.1. Promotional sales team market, 2018 - 2030 (USD Million)
      • 4.2.1.3. Key account management
      • 4.2.1.3.1. Key account management market, 2018 - 2030 (USD Million)
      • 4.2.1.4. Vacancy Management
      • 4.2.1.4.1. Vacancy Management market, 2018 - 2030 (USD Million)
    • 4.2.2. Non-Personal Promotion
      • 4.2.2.1. Non-Personal promotion market, 2018 - 2030 (USD Million)
      • 4.2.2.2. Medical affairs solutions
      • 4.2.2.2.1. Medical affairs solutions market, 2018 - 2030 (USD Million)
      • 4.2.2.3. Remote medical science liaisons
      • 4.2.2.3.1. Remote medical science liaisons market, 2018 - 2030 (USD Million)
      • 4.2.2.4. Nurse (clinical) educators
      • 4.2.2.4.1. Nurse (clinical) educators market, 2018 - 2030 (USD Million)
      • 4.2.2.5. Others
      • 4.2.2.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Sales Organization Market (CSO): End-use Segment Analysis

  • 5.1. Pharmaceutical Contract Sales Organization Market (CSO) Market: Definition & Scope
  • 5.2. Pharmaceutical Contract Sales Organization Market (CSO) Market: End Use Market Share Analysis, 2022 & 2030
    • 5.2.1. Pharmaceutical Companies
      • 5.2.1.1. Pharmaceutical companies Market, 2018 - 2030 (USD Million)
    • 5.2.2. Biopharmaceutical Companies
      • 5.2.2.1. Biopharmaceutical companies Market, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Sales Organization Market (CSO): Regional Analysis

  • 6.1. Pharmaceutical Contract Sales Organization Market (CSO): Regional market share analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Market estimates and forecast, 2018 - 2030
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Market estimates and forecast, 2018 - 2030
    • 6.2.3. Canada
      • 6.2.3.1. Canada Market estimates and forecast, 2018 - 2030
  • 6.3. Europe
    • 6.3.1. Europe Market estimates and forecast, 2018 - 2030
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Market estimates and forecast, 2018 - 2030
    • 6.3.3. Germany
      • 6.3.3.1. Germany Market estimates and forecast, 2018 - 2030
    • 6.3.4. France
      • 6.3.4.1. France Market estimates and forecast, 2018 - 2030
    • 6.3.5. Italy
      • 6.3.5.1. Italy Market estimates and forecast, 2018 - 2030
    • 6.3.6. Spain
      • 6.3.6.1. Spain Market estimates and forecast, 2018 - 2030
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Market estimates and forecast, 2018 - 2030
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Market estimates and forecast, 2018 - 2030
    • 6.3.9. Norway
      • 6.3.9.1. Norway Market estimates and forecast, 2018 - 2030
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
    • 6.4.2. Japan
      • 6.4.2.1. Japan Market estimates and forecast, 2018 - 2030
    • 6.4.3. China
      • 6.4.3.1. China Market estimates and forecast, 2018 - 2030
    • 6.4.4. India
      • 6.4.4.1. India Market estimates and forecast, 2018 - 2030
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
    • 6.4.6. Australia
      • 6.4.6.1. Australia Market estimates and forecast, 2018 - 2030
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Market estimates and forecast, 2018 - 2030
  • 6.5. Latin America
    • 6.5.1. Latin America Market estimates and forecast, 2018 - 2030
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Market estimates and forecast, 2018 - 2030
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Market estimates and forecast, 2018 - 2030
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Market estimates and forecast, 2018 - 2030
      • 6.6.MEA
    • 6.6.1. MEA Market estimates and forecast, 2018 - 2030
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Market estimates and forecast, 2018 - 2030
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
    • 6.6.4. UAE
      • 6.6.4.1. UAE Market estimates and forecast, 2018 - 2030
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Market estimates and forecast, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. CMIC HOLDINGS Co., LTD
      • 7.1.1.1. Company overview
      • 7.1.1.2. Financial performance
      • 7.1.1.3. Service benchmarking
      • 7.1.1.4. Strategic initiatives
  • 7.2. Axxelus
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Service benchmarking
      • 7.2.1.4. Strategic initiatives
  • 7.3. EPS Corporation.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
  • 7.4. QFR SOLUTIONS
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
  • 7.5. MaBico
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Service benchmarking
      • 7.5.1.4. Strategic initiatives
  • 7.6. Mednext Pharma Private Limited
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Service benchmarking
      • 7.6.1.4. Strategic initiatives
  • 7.7. Peak Pharma Solutions Inc.
      • 7.7.1.1. Company overview
      • 7.7.1.2. Financial performance
      • 7.7.1.3. Service benchmarking
      • 7.7.1.4. Strategic initiatives
  • 7.8. IQVIA, Inc.
      • 7.8.1.1. Company overview
      • 7.8.1.2. Financial performance
      • 7.8.1.3. Service benchmarking
      • 7.8.1.4. Strategic initiatives
  • 7.9. Promoveo Health
      • 7.9.1.1. Company overview
      • 7.9.1.2. Financial performance
      • 7.9.1.3. Service benchmarking
      • 7.9.1.4. Strategic initiatives
  • 7.10. Syneous Health
      • 7.10.1.1. Company overview
      • 7.10.1.2. Financial performance
      • 7.10.1.3. Service benchmarking
      • 7.10.1.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Pharmaceutical CSO market outlook, 2018 - 2030
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Pharmaceutical CSO market: Service outlook key takeaways
  • Fig. 15 Pharmaceutical CSO market: Service movement analysis
  • Fig. 16 Personal Promotion market, 2018 - 2030 (USD Million)
  • Fig. 17 Promotional sales team market, 2018 - 2030 (USD Million)
  • Fig. 18 Key account management market, 2018 - 2030 (USD Million)
  • Fig. 19 Vacancy management market, 2018 - 2030 (USD Million)
  • Fig. 20 Non-personal Promotion market, 2018 - 2030 (USD Million)
  • Fig. 21 Medical affairs solutions market, 2018 - 2030 (USD Million)
  • Fig. 22 Remote medical science liaisons market, 2018 - 2030 (USD Million)
  • Fig. 23 Nurse (clinical) educators market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceutical CSO market: End-use outlook key takeaways
  • Fig. 26 Pharmaceutical CSO market: End-use movement analysis
  • Fig. 27 Pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional marketplace: Key takeaway
  • Fig. 30 Pharmaceutical CSO market regional outlook, 2020 & 2028
  • Fig. 31 North America Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 36 France Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 46 India Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East & Africa Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Pharmaceutical CSO market, 2018 - 2030 (USD Million)